Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're looking into semaglutide in Belfast, the short answer is this: Wegovy (the branded semaglutide licensed for weight management) is available to adults across Northern Ireland through a private prescription following a clinical assessment, or through NHS specialist weight management services where eligible. Semaglutide is a prescription-only medicine, which means a qualified prescriber must review your health before any treatment is issued — no online form bypasses that step. Wegovy has been licensed in the UK for weight management since 2023, and Belfast residents have the same access routes as anyone else in the UK, with a few devolved-system nuances worth knowing.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide mimics a hormone called GLP-1 that the gut releases naturally after eating. By activating GLP-1 receptors, it signals to the brain that you are full sooner, dials down hunger between meals, and slows the speed at which food leaves the stomach. The result, for most people, is that significantly less food feels satisfying. That is why the effect on calorie intake can be substantial even without a rigid diet.
It is worth being clear that semaglutide is not simply a metabolism booster. The medicine works alongside a reduced-calorie diet and increased activity, not instead of them. Our full semaglutide guide explains the mechanism in more depth if you want the detail behind the clinical picture.
Two semaglutide products are licensed for weight management in the UK: the weekly Wegovy injection and, since June 2026, the Wegovy tablet, the first oral GLP-1 medicine approved for weight loss in the UK. Exploring both options before your consultation can help you arrive with a clearer sense of what might suit you.
Northern Ireland has its own devolved health system, so NHS criteria for weight-management medicines do not always mirror NHS England's phased rollout exactly. As a general rule, NICE recommends Wegovy (semaglutide) for adults with a BMI of 35 or above alongside at least one weight-related comorbidity, accessed through a specialist weight management service for a maximum of two years, per NICE technology appraisal TA875. In practice, the Health and Social Care (HSC) system in Northern Ireland commissions specialist services on its own timetable, and waiting lists can be long.
Lower BMI thresholds apply for some ethnic backgrounds under UK guidance, typically 2.5 kg/m² below the standard figure. And meeting a BMI threshold alone never guarantees access, a prescriber assesses the full clinical picture, including any conditions that might make the medicine unsuitable.
For people in Belfast who do not meet the current HSC criteria, or who would rather not wait, a private prescription from a regulated online pharmacy is a legal and well-established alternative. The FAQ section on our site covers common questions about private versus NHS access.
Getting semaglutide privately starts with a clinical consultation, not a checkout. A GPhC-registered Independent Prescriber reads your answers, reviews your health history, and decides whether treatment is appropriate. At nume, that review happens the same day your consultation is submitted. There is no algorithm making that call; a named clinician does.
If approved, the medicine is dispensed by our GPhC-registered pharmacy and sent by DPD tracked delivery the next working day, arriving in plain, unbranded packaging. When it comes, you will find the Wegovy pen itself inside, pre-filled, pre-set, ready to use once you have read the Patient Information Leaflet. The tracking link arrives on your phone beforehand so you know exactly when to expect it.
Pricing on private treatments varies by dose and provider. For context on what the market looks like and what a legitimate price should include, our Wegovy cost guide breaks it down honestly. One point worth making: any legitimate private price covers consultation, prescription, the medicine, and delivery, if a headline figure excludes any of those, the real cost is higher than it looks.
The most commonly reported effects are gastrointestinal: nausea, constipation, diarrhoea, and indigestion are all on the list. For most people these are mild to moderate and ease within the first few weeks as the body adjusts, with the starting semaglutide 1 mg dose typically being the point at which these effects are first noticed. They tend to be most noticeable after starting treatment or after a dose increase.
A small number of people experience more serious effects. Pancreatitis is an uncommon but recognised risk, if you develop severe stomach pain that reaches through to your back, with or without vomiting, get medical help promptly. The NHS semaglutide medicine page lists the full side-effect profile and sets out when to seek urgent care. Any suspected reaction can also be reported directly at the MHRA's Yellow Card scheme.
Semaglutide is not suitable during pregnancy or while trying to conceive, and it is not licensed for under-18s. If you take an oral contraceptive pill, tirzepatide (not semaglutide) has specific guidance about adding a second contraceptive method, your prescriber will go through what applies to you at consultation, including how dose progression through semaglutide 2 mg and on to the semaglutide 3 mg maintenance level is managed safely. Our clinical team reviews every case individually, and aftercare support is available seven days a week once you are on treatment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.